- cafead   Nov 14, 2023 at 09:22: AM
via UK biotech Autifony has signed an exclusive licensing deal with Jazz Pharmaceuticals, giving the Ireland-headquartered drugmaker global rights to a pair of ion channel targets associated with neurological disorders.
article source
article source